BridgeBio Pharma Security Sold Not Yet Repurchased (Quarterly) Insights

BridgeBio Pharma, Inc. (BBIO)

70.26 +1.95 (+2.85%) USD | NASDAQ | Feb 25, 09:48

View Security Sold Not Yet Repurchased (Quarterly) for BBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Security Sold Not Yet Repurchased (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Security Sold Not Yet Repurchased (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Mirum Pharmaceuticals, Inc.	--
Cogent Biosciences, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Sarepta Therapeutics, Inc.	--